Europe Viscosupplementation Market is Expected to Reach the value of USD 821.05 million by 2030
Data Bridge Market research has a newly released expansive study titled “Europe Viscosupplementation Market ” which guarantees you will remain better informed than your competition. This study provides a broader perspective of the marketplace with its comprehensive market insights and analysis which eases survival and success in the market.
Viscosupplements available in the market have shown clinical efficacy and are proven to be the most effective treatment for knee osteoarthritis. Osteoarthritis is a chronic painful degenerative joint disease and is the leading cause of chronic disability. The onset of the condition is mostly after 30 years of age, which may progress to develop into a disability after ten years of diagnosis.
However, the high cost associated with the drug and side effects such as temporary injection-site pain, swelling, heat or redness, rash or itching, bruising around the joint, and fluid accumulation in the injected knee may restrain the market’s growth.
Data Bridge Market Research analyzes that the Europe viscosupplementation market is expected to reach the value of USD 821.05 million by 2030, at a CAGR of 8.0% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-viscosupplementation-market&Shri
Viscosupplementation is a therapeutic process in which the pathological synovial fluid or effusion is removed from the joint by arthrocentesis and is replaced with a highly purified hyaluronan solution which has a 16- to 30-times greater concentration than the pathological joint fluid, and a 2- to 5-times than that of the hyaluronan in the healthy synovial fluid. In some preparations of hyaluronan for therapeutic purposes, the rheological properties (viscosity and elasticity) are low, and therefore the elastoviscosity of the fluid is similar to that of fluid removed from an arthritic joint. Another preparation available to patients worldwide is composed of hyaluronan derivatives (hylans) with substantially greater elastoviscosity than hyaluronan solutions and has comparable rheological properties to those of the fluid found in young, healthy individuals.
Drivers
- Rising Geriatric Population
With this increasing age comes a reciprocal increase in the number of elderly patients admitted to hospitals due to fatal traumatic injuries. Along with that, the rising prevalence of knee osteoarthritis diseases leads to increasing demand for diagnosis and treatment. The increasing need for proper treatment proportionally surges the demand for care, services, and technologies for the prevention and treatment of knee osteoarthritis conditions such as osteoporosis, osteopenia, and other complications. The elderly population is more prone to these conditions leading to fragile bones and joints. Viscosupplementation is used in the procedure to provide such patients with immediate and efficient benefits associated with their bodies.
- Increasing Risk of Osteoporosis and Osteoarthritis
Osteoporosis is a disease of bone that progresses due to less bone mineral density and bone mass or due to some variation in the quality or structure of bone. Osteoporosis could increase the risk of fractures leading to broken bones due to decreased bone strength. It is more observed in women as compared to men. The post-menstrual women often get bone fractures due to osteoporosis as the disease shows no symptoms. Most elderly people are more prone to osteoporosis. Osteoarthritis is a joint disease or an inflammation of the joints and surrounding tissues. The mobility of a person is affected when such conditions occur.
Silent diseases such as osteoporosis and osteoarthritis show no symptoms and weaken the person’s bone, leading to major fatalities such as spine malformation, fracture, sudden fall, or breakage of bone among others. Thus, the increased risks of these conditions directly enhance the demand for viscosupplementation required to treat the malformations that happened due to such conditions. Therefore, the increasing risk of osteoporosis and osteoarthritis is anticipated to drive the growth of the Europe viscosupplementation market.
Recent Developments
- In May 2022, Fidia Farmaceutici S.p.A. harnessed the regenerative power of hyaluronic acid with its innovative portfolio launched in Spain. Fidia Farmaceutici S.p.A. presented its Aesthetic Care portfolio with a scientific symposium on its innovative ACP (Auto-Crosslinked Polymer) technology at the 20th Aesthetic & Anti-aging Medicine World Congress 2022 (AMWC) in Monte Carlo. The company launched its complete Hyal System and Hy-Tissue portfolio in Spain. This helped the company to showcase its research for hyaluronic acid.
- In August 2021, SEIKAGAKU CORPORATION (announced the launch of HyLink, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Taiwan, through TCM Biotech International Corp. HyLink is an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis whose main ingredient is a cross-linked hyaluronate hydrogel made using Seikagaku’s unique cross-linking technology. This helped the company to expand its product portfolio.
Fundamental Aim of this Market Report
- Factors influencing This Market Size and growth rate.
- Major alterations to this market in the near future.
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Some of the major players operating in the Europe viscosupplementation market are Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.p.A, and Ferring B.V, sanofi-aventis U.S. LLC, Zimmer Biomet, APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, TRB CHEMEDICA SA, and Teva Pharmaceutical Industries Ltd. among others.
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/europe-viscosupplementation-market?Shri
Europe Viscosupplementation Market Scope
Source
- Animal Origin
- Non-Animal Origin
On the basis of source, the Europe viscosupplementation market is segmented into animal origin and non-animal origin.
Molecular Weight
- High Molecular Weight
- Low Molecular Weight
- Intermediate Molecular Weight
On the basis of molecular weight, the Europe viscosupplementation market is segmented into intermediate molecular weight, low molecular weight, and high molecular weight.
Injection
- Single Injection
- Three Injection
- Five Injection
On the basis of injection, the Europe viscosupplementation market is segmented into single injection, three injection, and five injection.
Age Group
- Adult
- Geriatric
On the basis of age group, the Europe viscosupplementation market is segmented into geriatric and adult.
End User
- Hospitals
- Orthopedic Clinics
- Ambulatory Care Center
- Others
On the basis of end user, the Europe viscosupplementation market is segmented into hospitals, orthopedic clinics, ambulatory care center, and others.
Distribution Channel
- Direct Tender
- Retail Sales
On the basis of distribution channel, the Europe viscosupplementation market is segmented into direct tender and retail sales.
Key highlights of this Market report:
- Growth rate
- Remuneration prediction
- Consumption graph
- Market concentration ratio
- Secondary industry competitors
- Competitive structure
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
What benefits does the DBMR study is going to provide?
- Latest industry influencing trends and development scenario
- Open up New Markets
- To Seize powerful market opportunities
- Key decision in planning and to further expand market share
- Identify Key Business Segments, Market proposition & Gap Analysis
- Assisting in allocating marketing investments
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Market Regulations
- Market Overview
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=europe-viscosupplementation-market&Shri
Key Benefits of the Report:
- This study presents the analytical depiction of this industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of this market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed this industry analysis based on competitive intensity and how the competition will take shape in the coming years.
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-viscosupplementation-market
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
